Skip to main content

Featured

A Monarch’s Message: King Charles III Opens Up About Cancer Journey

                                        King Charles will address the nation regarding his cancer diagnosis and recovery. King Charles III will deliver a rare televised message tonight, reflecting on his cancer diagnosis and recovery while urging the public to prioritize early screening. The address, recorded at Clarence House, marks one of the most open disclosures ever made by a British monarch regarding personal health. Diagnosed with cancer in February 2024, the King has undergone nearly two years of treatment. His decision to share his journey publicly represents a significant departure from royal tradition, as the monarchy has historically kept medical matters private. During the broadcast, Charles is expected to highlight the importance of early detection and screening, emphasizing how timely medical intervention can save lives. The message forms part of the...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment